Silver Book Fact

A meta-analysis of duloxetine, an anti-depressant, found a 50% reduction in pain at 12 weeks for diabetic peripheral neuropathy, and a 50% reduction in pain at 12 weeks for fibromyalgia.

Lunn M, Hughes R, Wiffen P. Duloxetine for Treating Painful Neuropathy or Chronic Pain. Cochrane Database of Systematic Reviews. 2009; 4. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007115.pub2/abstract

Reference

Title
Duloxetine for Treating Painful Neuropathy or Chronic Pain
Publication
Cochrane Database of Systematic Reviews
Publication Date
2009
Authors
Lunn M, Hughes R, Wiffen P
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • The Mayo Clinic Pain Rehabilitation Center helps people with persistent pain return to an active lifestyle and has found that among patients who finish the program, nearly 84% report greater…  
  • A meta-analysis of duloxetine, an anti-depressant, found a 50% reduction in pain at 12 weeks for diabetic peripheral neuropathy, and a 50% reduction in pain at 12 weeks for fibromyalgia.  
  • The combination of information for neuroimaging and circulatory biomarkers could improve both the sensitivity and specificity of pain diagnosis and thereby improve treatment.  
  • Brain imaging is showing that pain changes the structure and function of brain regions that perceive pain, making it persistent. These brain networks and receptor targets are being identified…  
  • Targeting A-type K+ channels in primary sensory neurons could provide a novel mechanism-based therapy for the treatment of bone cancer pain–one of the most severe types of chronic pain.